{"id":"W2522016206","doi":"","title":"Three unique antibodies demonstrate therapeutic effects against CD63, a novel target for cancer therapy","year":2005,"lang":"en","type":"article","venue":"","topic":"Cell Adhesion Molecules Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Arius3D (Canada)","funders":"","keywords":"Tetraspanin; Cancer; Antibody; Cancer research; Breast cancer; Antigen; Melanoma; Medicine; Tumor progression; Immunology; Prostate cancer; CD63; Biology; Internal medicine; Microvesicles; Cell","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000229637,0.0004650683,0.0003873404,0.0003549319,0.0001698478,0.0003373114,0.0002397218,0.0007186627,0.001771697],"category_scores_gemma":[0.0001532568,0.0001335972,0.0003929905,0.0001646646,0.0001391756,0.0001699439,0.0001927427,0.000841598,0.0004889514],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003742918,"about_ca_system_score_gemma":0.000206429,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004610448,"about_ca_topic_score_gemma":0.0007603629,"domain_scores_codex":[0.9998282,0.0000254272,0.00001368603,0.00002459262,0.00004926648,0.00005880764],"domain_scores_gemma":[0.9998939,0.00001674359,0.00001770173,0.000009938657,0.00002932852,0.00003237109],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0003035609,0.0003012449,0.0003709682,0.000123014,0.00002678797,0.0001443954,0.00003381818,0.0001977971,0.9561632,0.0005765254,0.0009604548,0.0407982],"study_design_scores_gemma":[0.0003932432,0.00432053,0.007814581,0.00003239019,0.0001376775,0.002895239,0.0000263877,0.001828383,0.9408246,0.0002866356,0.04141659,0.00002373166],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9529165,0.01433771,0.01099892,0.0009061165,0.0003217763,0.0003264446,0.0004428004,0.0005052324,0.0192445],"genre_scores_gemma":[0.9761213,0.004811177,0.009175268,0.0005790874,0.00008105736,0.0002051114,0.0009182082,0.00003036276,0.008078353],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001771697,"threshold_uncertainty_score":0.005926907,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0440750045662246,"score_gpt":0.3511186388473804,"score_spread":0.3070436342811558,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}